**Core Concept**
The "sick cell syndrome" refers to a condition where patients with chronic hemodialysis develop a normocytic anemia due to inadequate erythropoietin production, leading to decreased red blood cell mass. This condition is often associated with the uremic environment and the dialysis process itself.

**Why the Correct Answer is Right**
The "sick cell syndrome" occurs due to the reduced production of erythropoietin (EPO) by the kidneys in response to chronic hemodialysis. EPO is essential for the production of red blood cells in the bone marrow. In patients with chronic kidney disease, the kidneys are unable to produce sufficient EPO, leading to a decrease in red blood cell mass and the development of anemia. This condition is further exacerbated by the dialysis process, which can lead to the loss of iron and other essential nutrients required for erythropoiesis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the "sick cell syndrome" is not primarily caused by iron deficiency anemia, although iron deficiency can contribute to the development of anemia in patients with chronic kidney disease.

**Option B:** This option is incorrect because the "sick cell syndrome" is not solely caused by inflammation, although inflammation can contribute to the development of anemia in patients with chronic kidney disease.

**Option C:** This option is incorrect because the "sick cell syndrome" is not primarily caused by blood loss, although blood loss can contribute to the development of anemia in patients with chronic kidney disease.

**Clinical Pearl / High-Yield Fact**
The "sick cell syndrome" highlights the importance of EPO replacement therapy in patients with chronic kidney disease undergoing hemodialysis. Regular EPO supplementation can help to improve red blood cell mass and reduce the severity of anemia in these patients.

**Correct Answer: D.**